Press Releases Becton, Dickinson and Company

Equities

BDX

US0758871091

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:02 2026-03-06 pm EST			Pre-market 08:51:47 am
167.12 ^USD	-1.66%		167.45	+0.20%

Mar. 05	Bd advances iliac artery treatment across the European Union	RE
Mar. 02	Becton, Dickinson and Company Receives 510(K) Clearance from the U.S. Food and Drug Administration for the Surgiphor?? 1000Ml	CI

Press Releases

Mar. 02	BD Pioneers New Standard in Surgical Safety with FDA-Cleared Surgiphor™ 1000mL for Wound Irrigation	PR
Feb. 25	Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase	PR
Feb. 25	Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap	PR
Feb. 23	BD to Present at Barclays 28th Annual Global Healthcare Conference	PR
Feb. 23	BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency	PR
Feb. 19	Lanesha Minnix Named General Counsel for BD	PR
Feb. 10	Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities	PR
Feb. 09	Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses	PR
Feb. 09	Becton Dickinson: Fiscal Q1 Earnings Snapshot	AQ
Feb. 09	Becton Dickinson and : Earnings Release Q1 FY26	PU
Feb. 09	Becton Dickinson and : Presentation Q1 FY26	PU
Feb. 09	BD Reports First Quarter Fiscal 2026 Financial Results	PR
Jan. 29	BD and Envetec Demonstrate Closed-Loop Recycling Solution for Laboratory Plastics in Health Care	PR
Jan. 27	BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26	PR
Jan. 27	BD to Announce Financial Results for its First Quarter of Fiscal 2026	PR
Jan. 23	BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation	PR
Jan. 23	BICO company Biosero launches GoSimple™, a standardized automation-ready workcell with selected instruments from Sartorius and Becton, Dickinson and Company (BD)	AQ
Jan. 21	BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market	PR
Jan. 19	Becton Dickinson and : BD to Highlight Advanced Biologics and Large-Volume Delivery Solutions at Pharmapack 2026	PU
Jan. 16	BD Receives FDA 510(k) Clearance for EnCor EnCompass Breast Biopsy and Tissue Removal System	AQ
Jan. 15	BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System	PR
Jan. 14	BD Names Shawn Bevec as Senior Vice President of Investor Relations	PR
Jan. 13	BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs	PR
Jan. 12	BD To Host Virtual 2026 Annual Meeting of Shareholders	PR
Jan. 05	BD Marks Milestone with First Phasix™ Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT Trial	PR